4.7 Article

Comparison of Cumulative Live Birth Rates between Flexible and Conventional Progestin-Primed Ovarian Stimulation Protocol in Poor Ovarian Response Patients According to POSEIDON Criteria: A Cohort Study

Related references

Note: Only part of the references are listed.
Review Endocrinology & Metabolism

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF

Raoul Orvieto

Summary: Ovarian stimulation is crucial for the success of in vitro fertilization-embryo transfer, and the use of GnRH-ag/GnRH-ant can enhance its effectiveness in challenging cases such as poor responders and patients with elevated progesterone levels. It allows better cycle programming and follicular synchronization, resulting in successful outcomes.

REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2023)

Article Obstetrics & Gynecology

The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF

N. Massin et al.

Summary: This study compares the effectiveness of two treatment protocols in assisting conception for patients with poor ovarian response, and the results show that there is no significant difference in the number of oocytes retrieved between the dual ovarian stimulation in the same cycle and two consecutive antagonist cycles.

HUMAN REPRODUCTION (2023)

Article Endocrinology & Metabolism

Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score-matched cohort study

Mingze Du et al.

Summary: This study compared the neonatal outcomes of progestin-primed ovarian stimulation (PPOS) and flexible gonadotropin-releasing hormone (GnRH) antagonist protocols. The results showed that there were no significant differences in preterm birth, low birth weight, small for gestational age, macrosomia, and large for gestational age between PPOS and GnRH antagonist protocols.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Obstetrics & Gynecology

Effectiveness of the flexible progestin primed ovarian stimulation protocol compared to the flexible GnRH antagonist protocol in women with decreased ovarian reserve

Engin Turkgeldi et al.

Summary: The aim of this retrospective cohort study was to compare the effectiveness of the new flexible progestin primed ovarian stimulation (fPPOS) protocol with the flexible gonadotropin-releasing-hormone antagonist (GnRH-ant) protocol in women with decreased ovarian reserve (DOR). The results showed that fPPOS may be used as a viable alternative to the flexible GnRH-ant protocol for women with DOR without compromising the number of oocytes retrieved.

HUMAN FERTILITY (2022)

Article Endocrinology & Metabolism

The Comparison of Fixed and Flexible Progestin Primed Ovarian Stimulation on Mature Oocyte Yield in Women at Risk of Premature Ovarian Insufficiency

Erkan Kalafat et al.

Summary: In women with diminished ovarian reserve, flexible and fixed PPOS regimens showed no significant differences in MII oocyte yield and incidence of premature LH surges.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Obstetrics & Gynecology

POSEIDON groups and their distinct reproductive outcomes: Effectiveness and cost- effectiveness insights from real-world data research

Sandro C. Esteves et al.

Summary: The POSEIDON criteria can identify and classify low-prognosis patients in assisted reproductive technology, and recent studies using real-world data have validated the effectiveness of this system and provided corresponding reproductive outcomes.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2022)

Article Medicine, General & Internal

Are There Ovarian Responsive Indexes That Predict Cumulative Live Birth Rates in Women over 39 Years?

Sara Cesarano et al.

Summary: This study aimed to evaluate the performance of ovarian response indexes in predicting cumulative assisted reproductive technology (ART) outcomes in women aged 39 and above. The study found that the Ovarian Sensitivity Index (OSI) performed the best in predicting cumulative live birth rate (cLBR) and implantation rate, while the Follicle Oocyte Index (FOI) and Follicular Output Rate (FORT) were also associated with embryo culture success and the number of MII oocytes collected.

JOURNAL OF CLINICAL MEDICINE (2022)

Review Obstetrics & Gynecology

Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses

Baris Ata et al.

Summary: This review provides a comprehensive analysis of the mechanism, effectiveness, and cost-effectiveness of progestins for pituitary suppression in assisted reproductive technology (ART). Future research priorities have been identified to further explore the use of progestins in ART.

HUMAN REPRODUCTION UPDATE (2021)

Article Reproductive Biology

New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone

Nanako Iwami et al.

Summary: This study compared the efficacy of the progestins Dienogest (DNG) and Dydrogesterone (DYG) in patients undergoing progestin-primed ovarian stimulation (PPOS) during controlled ovarian hyperstimulation (COH) for endometriosis treatment. The results showed that the DNG group had a higher rate of mature oocytes compared to the DYG group, while fertilization rates were similar between the two groups. Therefore, patients receiving DNG for PPOS can continue endometriosis treatment and obtain good-quality embryos during COH.

REPRODUCTIVE BIOLOGY (2021)

Article Endocrinology & Metabolism

Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines

Sandro C. Esteves et al.

Summary: The POSEIDON criteria were developed to help identify low-prognosis patients undergoing assisted reproductive technology and guide therapeutic strategies. However, existing evidence shows inconsistent and incomplete reporting, prompting the development of guidelines to improve reporting quality. The ultimate goal is to advance knowledge on the clinical use of POSEIDON criteria for the benefit of patients, clinicians, and the infertility community.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Obstetrics & Gynecology

Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients

Sandro C. Esteves et al.

Summary: Patients classified under the POSEIDON criteria generally have a lower cumulative delivery rate (CDR) in IVF/ICSI treatment compared to normal responders, with differences primarily influenced by female age and the number of oocytes retrieved.

HUMAN REPRODUCTION (2021)

Article Endocrinology & Metabolism

Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study

Shaodi Zhang et al.

Summary: In low-prognosis patients according to POSEIDON criteria, the cumulative live birth rate (CLBR) was significantly higher with a GnRH antagonist regimen compared to a PPOS regimen. The difference was especially pronounced in patients over the age of 35 with poor ovarian reserve.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Obstetrics & Gynecology

A meta-analysis of the efficacy of progestin-primed ovarian stimulation with medroxyprogesterone acetate in ovulation induction in poor ovarian responders

Ruihong Cai et al.

Summary: PPOS is more effective in patients with poor ovarian response compared to other ovulation induction protocols, as it reduces the need for cycle cancellation, improves follicles and embryos, and enhances pregnancy rates.

JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2021)

Article Genetics & Heredity

Impact of progestin ovarian stimulation on newborn outcomes: a meta-analysis

Irene Zolfaroli et al.

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2020)

Article Public, Environmental & Occupational Health

Comparison Between PPOS and GnRHa-Long Protocol in Clinical Outcome with the First IVF/ICSI Cycle: A Randomized Clinical Trial

Qianwen Xi et al.

CLINICAL EPIDEMIOLOGY (2020)

Article Chemistry, Medicinal

Live-Birth Outcomes and Congenital Malformations After Progestin-Primed Ovarian Stimulation in Maternal Endometriosis

Zhou Liang et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

Article Obstetrics & Gynecology

Cumulative live birth rates in low-prognosis women

Jori A. Leijdekkers et al.

HUMAN REPRODUCTION (2019)

Article Obstetrics & Gynecology

The combined impact of maternal age and body mass index on cumulative live birth following in vitro fertilization

Randi H. Goldman et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2019)

Review Endocrinology & Metabolism

Management Strategies for POSEIDON Groups 3 and 4

Thor Haahr et al.

FRONTIERS IN ENDOCRINOLOGY (2019)

Article Medicine, General & Internal

Transfer of Fresh versus Frozen Embryos in Ovulatory Women

Yuhua Shi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Medicine, General & Internal

Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome

Zi-Jiang Chen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)